MedPath

Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

Not yet recruiting
Conditions
Teenagers
Registration Number
NCT06631794
Lead Sponsor
Hopital Foch
Brief Summary

This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination.

This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.

Detailed Description

The main aim of the present study is to investigate the impact of HPV vaccination talk with 3rd grade school children on HPV vaccine dispensing by making them actors in their own health. A significant benefit on vaccination coverage is expected. In addition, a flyer providing information and raising awareness of infections and the benefits of HPV vaccination will be sent to parents at the end of the talk.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
1170
Inclusion Criteria
  • 3rd grade students enrolled in public secondary schools in Suresnes and Rueil-Malmaison.
Read More
Exclusion Criteria
  • Students absent on the day of the talk.
  • Students unwilling/unable to complete questionnaire.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Impact Assessement of a sexual health talk with middle school students in 3rd grade on the dispensation of HPV vaccines among young people born in 2010.12 months preceding the talk and the 6 months following the talk

The aim of this study is to evaluate the impact of a sexual health talk with middle school students in 3rd grade on the dispensation of HPV vaccines among young people born in 2010.

The main evaluation criterion for this study is the number of monthly HPV vaccine dispensations among young people born between 01/01/2010 and 31/12/2010. These data will be communicated by the OSPHARM cooperative or by pharmacies, over the 12 months preceding the talk and the 6 months following, in order to be able to assess the impact of the latter on dispensations.

Secondary Outcome Measures
NameTimeMethod
1rst Secondary outcoume8 weeks

Evaluate the implementation of sexuality education sessions as part of middle school educational programs.

2nd Secondary outcoume8 weeks

Evaluate the knowledge of Suresnes and Rueil-Malmaison 3rd grade students about HPV infection and HPV vaccination before and after the talk.

This outcome will be evaluated through questionnaire

3rd secondary outcoume8 weeks

Evaluate middle-school students; satisfaction with the HPV vaccination information talk.

This outcome will be evaluated through questionnaire

4 th secondary outcoume8 weeks

Evaluate adherence to the sexual health talk by Suresnes and Rueil-Malmaison middle schools.

This outcome will be assessed through the mesearement of the rate of completed questionnaires

5 th secondary outcoume6 months after talk

Estimating the rate of young people born in 2010 vaccinated against HPV by gender.

The estimation rate will be calculated with data collected from the ospharm cooperative application.

© Copyright 2025. All Rights Reserved by MedPath